💨 Abstract
Milestone Pharmaceuticals Inc. (MIST) reported a second-quarter loss of $13 million, or 20 cents per share, missing Wall Street expectations of an 18-cent loss per share. The company, based in Montreal, fell short of analysts' forecasts despite these losses. This financial update was generated by Automated Insights using data from Zacks Investment Research.
Courtesy: WTOP Staff
Suggested
Leaving a top Trump administration post? The president may have an ambassadorship for you -
US briefly deploys 2 warships to a disputed South China Sea shoal after Chinese collision -
Spain women’s team coach Montse Tomé is ‘disappointed’ after not having her contract extended -
GE Appliances shifts more production to US as part of a $3 billion investment -
Trump will be at the Kennedy Center on the same day recipients of the honors are announced -
Creative Media & Community Trust: Q2 Earnings Snapshot -
La alcaldesa de Washington, Muriel Bowser, cambia su tono hacia Trump mientras se intensifica la represión -
Bangladeshi officials testify against former British minister Tulip Siddiq in anti-corruption trial -
Japanese pop idol Kenshin Kamimura convicted of indecent assault but avoids jail in Hong Kong -
It could be the most open Premier League title race in years as clubs spend big to take advantage -